Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration

Author(s):  Lu Juan, Liu Qiang, Kupiec Thomas C, Vail Herbert, Lynch Leslie R, Fam David S, Vu Nicole T

Issue:  Jan/Feb 2021 - Volume 25, Number 1
View All Articles in Issue

Abstract:  The physical compatibility of cefiderocol for injection (prepared as a diluted 2% cefiderocol solution) with potential co-administration drug products is presented. The compatibility of cefiderocol with a selection of 91 intravenous drugs was tested at clinically relevant concentrations using the admixed volume ratio 1:1. Compatibility of the mixtures was determined by visual observations, turbidity, and particulate-matter measurements. The mixtures were examined immediately after mixing, and then at 1 hour and 4 hours thereafter at room temperature. When using 0.9% sodium chloride or 5% dextrose injection for diluents, solutions of dobutamine hydrochloride, esomeprazole sodium, methylprednisolone acetate, propofol, rocuronium bromide, amiodarone hydrochloride, famotidine, labetalol hydrochloride, mycophenolate mofetil, acyclovir sodium, amphotericin B, caspofungin acetate, doxycycline, posaconazole, diphenhydramine hydrochloride, and phenytoin sodium were found to cause visible cloudiness upon mixing with 2% cefiderocol in both diluents. Solutions of lorazepam, tobramycin sulfate, and vancomycin hydrochloride were determined incompatible by examining the mixtures with the aid of a Tyndall light. These 19 drugs were clearly incompatible with cefiderocol for injection by visual examination. In addition, solutions of iron sucrose and albumin were incompatible with 2% cefiderocol based on sub-visual tests for turbidity and/or particulate matter. Based on sub-visual data, the 0.9% sodium chloride admixture of aminophylline and 2% cefiderocol was incompatible, while inconclusive results were obtained for the 0.9% sodium chloride admixtures of 2% cefiderocol with amikacin sulfate. Similarly, the 5% dextrose admixtures of either ciprofloxacin or polymyxin B sulfate with 2% cefiderocol were incompatible, whereas data for phenylephrine hydrochloride morphine sulfate, or undiluted sodium bicarbonate were inconclusive. Overall, the 2% cefiderocol solution was physically compatible with 63 of 91 drugs challenged at 1:1 volume ratio in both 0.9% sodium chloride and 5% dextrose diluents for at least 4 hours at the concentrations tested in this study.

Related Keywords: Juan Lu, MS, Qiang Liu, PhD, Thomas C. Kupiec, PhD, Herbert Vail, BS, Leslie R. Lynch, MS Eng, David S. Fam, PharmD, Nicole T. Vu, PhD, cefiderocol, siderophore cephalosporin antibiotic, drug admixtures, intravenous infusion, parenteral administration, drug incompatibility, physical compatibility

Related Categories: EXCIPIENTS, FORMULATIONS, INFECTIOUS DISEASE

Printer-Friendly Version




Download in electronic PDF format for $45

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration Lu Juan, Liu Qiang, Kupiec Thomas C, Vail Herbert, Lynch Leslie R, Fam David S, Vu Nicole T Jan/Feb 2021 52-61 Buy
Zinc Content of Commercial Diluents Widely Use in Drug Admixtures Prepared for Intravenous Infusion Desai Narendra R, Shah Syed M, Koczone Julianna, Vencl-Joncic Maja, Sisto Christopher, Ludwig Stephen A Sep/Oct 2007 426-432 Buy
Palonosetron Hydrochloride Compatibility and Stability with Three Beta-Lactam Antibiotics During Simulated Y-Site Administration Ben Michel, Trusley Craig, Kupiec Thomas C, Trissel Lawrence A Nov/Dec 2007 520-524 Buy
A Review of Parenteral Admixtures Requiring Select Containers and Administration Sets Rice Stephen P Mar/Apr 2002 120-122 Buy
Topical Metered-dosing Dispenser Performance Evaluation Liu Qiang, Kupiec Thomas C, Vu Nicole T May/Jun 2016 239-246 Buy
Compatibility of Caspofungin Acetate Injection with Other Drugs During Simulated Y-Site Coadministration Chan Pak, Heatherly Kathy, Kupiec Thomas C, Trissel Lawrence A May/Jun 2008 276-278 Buy
Compatibility and Stability of Palonosetron Hydrochloride and Propofol During Simulated Y-Site Administration Trissel Lawrence A, Trusley Craig, Kupiec Thomas C, Ben Michel Jan/Feb 2009 78-80 Buy
Intravenous Admixture Preparation Considerations, Part 2: Incompatibilities and Factors Involved Allen Loyd V Jr Jan/Feb 2020 44-50 Buy
Chemical Stability of Admixtures Containing Ziconotide 25 mcg/mL and Morphine Sulfate 10 mg/mL or 20 mg/mL During Simulated Intrathecal Administration Shields David E, Aclan Jennifer, Szatkowski Aaron Nov/Dec 2008 553-557 Buy
Compatibility and Stability of Palonosetron Hydrochloride with Gentamicin, Metronidazole, or Vancomycin During Simulated Y-Site Administration Kupiec Thomas C, Ben Michel, Trusley Craig, Trissel Lawrence A Mar/Apr 2008 170-173 Buy